Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
PharmAust Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. PharmAust Limited was incorporated in 2000 and is based in Melbourne, Australia.
Show more...
FAQ
Apa simbol saham Pharmaust?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa Boerse Stuttgart, saham Pharmaust diperdagangkan dengan simbol ECQ.STU.
Berapa pendapatan Pharmaust tahun lalu?▼
Pendapatan Pharmaust tahun lalu berjumlah 0 EUR.
Berapa pendapatan bersih Pharmaust tahun lalu?▼
Pendapatan bersih ECQ.STU untuk tahun lalu adalah -9,55M EUR.
Pharmaust berada di sektor apa?▼
Pharmaust beroperasi di sektor Kesehatan & Kebugaran.
Kapan Pharmaust menyelesaikan split saham?▼
Pharmaust belum melakukan split saham baru-baru ini.
Di mana kantor pusat Pharmaust?▼
Kantor pusat Pharmaust berlokasi di Melbourne, Australia.